Ajit Nalawade

Current Positions: Consultant Rheumatologist & Director: Coherence Pain & Arthritis Clinics-Dhole Patil Road, Pune 1 & Magarpatta road, Pune 28, Maharashtra, India Rheumatologist & Head of the Department: Sancheti Hospital, Pune 411005. India Consultant Rheumatologist: Ruby Hall Clinic & Grant Medical foundation, Pune 411001, India Underwent internal medicine and rheumatology training and certification at Seth GS Medical College and KEM Hospital, Mumbai. Fellowship of ACR - 2014 Recipient of European Certificate of Rheumatology from European College of Rheumatology-EULAR congress 2018. Founding member and treasurer – MRA (association of rheumatologists in Maharashtra). Founded Focus Arthritis foundation along with other initiatives for awareness and education of rheumatic diseases in community, patients and primary healthcare providers. Principal investigator on global clinical trials and expert member on Data & Safety Monitoring Board of a Phase Il global study. Publications, recent papers: 1. Pharmacokinetic Similarity and Comparative Pharmacodynamics, Safety, Efficacy, and Immunogenicity of DRL_RI Versus Reference Rituximab in Biologic- Naïve Patients with Moderate-to-Severe Rheumatoid Arthritis: A Double- Blind, Randomized, Three- Arm Study. V M Haridas, Ajit Nalawade, Luis Lpez- Lazaro et al. BioDrugs volume 34, pages 183–196(2020) 2. Study of 3 Anti CD20 Monoclonal Antibodies in Moderate to Severe Seropositive RA: Efficacy, Safety & Immunogenicity Results. V. Haridas, Ajit Nalawade et al. Canadian Rheumatology Association conference, Vancouver, Feb 2018 3. Pharmacokinetics and Pharmacodynamics of 3 Anti CD20 Monoclonal Antibodies in Moderate to Severe Seropositive RA. Ajit Nalawade et al, Canadian Rheumatology Association conference, Vancouver, Feb 2018 4. Long term safety of methotrexate in patients with RA in routine practice. Ajit Nalawade et al. EULAR 2017, Madrid. 5. Diffuse idiopathic skeletal hyperostosis. Nalawade A, Oyoo GO. Afr J Rheumatol 2016; 3(1): 31-34